A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 4, 2004, Pages 828-831

  Szczypa, Katarzyna ^a   Sadowy, Ewa ^a   Izdebski, Radosław ^a   Hryniewicz, Waleria ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Erythromycin resistance; Genotypes; Phenotypes; S. pyogenes

Indexed keywords

AZITHROMYCIN; BACTERIAL DNA; BACTERIAL PROTEIN; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; LINEZOLID; MACROLIDE; MOXIFLOXACIN; PENICILLIN G; ROXITHROMYCIN; SPIRAMYCIN; TELITHROMYCIN; TETRACYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CLINICAL OBSERVATION; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; GENE LOCUS; GENE SEQUENCE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NONHUMAN; POLAND; PULSED FIELD GEL ELECTROPHORESIS; SEROPREVALENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENES, BACTERIAL; GENOTYPE; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; POLAND; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 6344258817     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh420     Document Type: Article

References (13)

1. Leclercq, R. (2002). Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clinical Infectious Diseases 34, 482-92.
2. National Committee for Clinical Laboratory Standards. (2004). Performance Standards for Antimicrobial Susceptibility Testing; Fourteenth Informational Supplement M100-S14. NCCLS, Wayne, PA, USA.
3. Report of the Comité de l'Antibiogramme de la Société Française de Microbiologie. (1996). Statement 1996 CA-SFM. Zone sizes and MIC breakpoints for non-fastidious organisms. Clinical Microbiology and Infection 2, Suppl. 1, 46-9.
4. Kataja, J., Huovinen, P., Skurnik, M. et al. (1999). Erythromycin resistance genes in group A streptococci in Finland. Antimicrobial Agents and Chemotherapy 43, 48-52.
5. Sutcliffe, J., Grebe, T., Tait-Kamradt, A. et al. (1996). Detection of erythromycin-resistant determinants by PCR. Antimicrobial Agents and Chemotherapy 40, 2562-6.
6. Stanley, J., Linton, D., Desai, M. et al. (1995). Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease. Journal of Clinical Microbiology 33, 2850-5.
7. Tenover, F. C., Arbeit, R. D., Goering, R. et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 33, 2233-9.
8. Enright, M. C., Spratt, B. G., Kalia, A. et al. (2001). Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infection and Immunity 69, 2416-7.
9. Jasir, A., Tanna, A., Noorani, A. et al. (2000). High rate of tetracycline resistance in Streptococcus pyogenes in Iran: an epidemiological study. Journal of Clinical Microbiology 38, 2103-7.
10. Arvand, M., Hoeck, M., Hahn, H. et al. (2000). Antimicrobial resistance in Streptococcus pyogenes isolates in Berlin. Journal of Antimicrobial Chemotherapy 46, 621-3.
11. Morosini, M. I., Cantón, R., Loza, E. et al. (2003). Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin. Journal of Antimicrobial Chemotherapy 52, 50-5.
12. Nagai, K., Appelbaum, P. C., Davies, T. A. et al. (2002). Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 Central and Eastern European Countries. Antimicrobial Agents and Chemotherapy 46, 546-9.
13. Reinert, R. R., Lütticken, R., Sutcliffe, J. A. et al. (2004). Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany. Antimicrobial Agents and Chemotherapy 48, 1369-73.